What does USP 797 compliance mean for 503B insurance?

USP General Chapter <797> is the standard for sterile compounding compliance, mandatory for 503B outsourcing facilities and 503A sterile compounding pharmacies. It addresses environmental monitoring, beyond-use dating, competency training, garbing and aseptic technique, and quality assurance for sterile preparations.

Insurance carriers use USP 797 compliance posture as a key underwriting input. Clean USP 797 compliance documented through state board or FDA inspection produces premium credits in the 5 to 15 percent range across products liability, druggist professional liability, and cGMP property lines.

USP 797 deficiencies, especially environmental monitoring gaps or beyond-use dating issues, produce material premium increases - typically 20 to 50 percent at renewal - and can produce coverage gaps where carriers add specific exclusions tied to the deficient operation.

2026 cycle expectation: carriers are increasingly requiring USP 797 attestation as part of standard renewal submissions. Operators that did not historically document USP 797 compliance posture in submissions should expect to start.